Beximco Pharmaceuticals Ltd

BXP

Equity

ISIN US0885792061 / Valor 2318407

LSE London Stock Exchange, SETS (2024-11-21)

GBP 0.34%

Beximco Pharmaceuticals Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Beximco Pharmaceuticals Ltd., established in 1976 and headquartered in Dhaka, Bangladesh, is a prominent manufacturer and exporter of medicines and active pharmaceutical ingredients (APIs). Initially, the company began by importing and selling products from Bayer AG and Upjohn Inc. in the local market, later transitioning to manufacturing these products under licensing agreements in 1980. By 1983, Beximco Pharma had launched its own formulation brands. Over the years, the company has expanded significantly, now exporting to over 50 countries, including highly regulated markets such as the USA, Europe, Canada, and Australia. Beximco Pharma's manufacturing facilities are accredited by leading global regulatory authorities. The company employs over 4,700 professionals across various disciplines. In recent strategic moves, Beximco Pharma acquired a majority stake in Sanofi Bangladesh Limited in 2021, which was subsequently renamed Synovia Pharma PLC. The company is also notable for being the only Bangladeshi firm listed on the AIM of the London Stock Exchange.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.7%1Y

-65.5%3Y

-9.97%5Y

Performance

54.6%1Y

63.0%3Y

60.5%5Y

Volatility